# Laverock Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/laverock-therapeutics

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.laverocktx.com
- Total disclosed funding: $26M
- Latest round: Seed (Jun 1, 2025)
- Investors on record: 10

## About

Based in London, UK, and founded in 2021, Laverock Therapeutics, formerly known as Skylark Therapeutics Limited, operates as a developer of gene silencing systems to create programmable cell therapies for the next generation. In June 2025, Laverock Therapeutics Limited raised GBP 6.5 million in seed funding led by returning investor Calculus Capital, with participation from other returning investors Eli Lilly & Company, Mercia Asset Management, Eos Venture Partners, and Maven Capital Partners. New investor Norcliffe Capital also participated in the round. The company offers various gene editing solutions that include Gene Editing induced Gene Silencing (GEiGS®) used for gene editing tools offering gene editing workflows and assessment of off-target profiles. The company also provides a bioinformatics platform that uses GEiGS® technology for the development of allogeneic adoptive cell treatments targeting specific endogenous or exogenous genes. The company will use the June 2025 funding for platform development.

## Funding rounds

- Seed, Jun 1, 2025, $8.8M — Maven Capital Partners, Mercia Asset Management, Calculus Capital, Eli Lilly & Company, Eos Ventures, Norcliffe Capital
- Seed, Sep 18, 2023, $17M — Mercia Asset Management, Calculus Capital, Eli Lilly & Company, Tekfen Ventures, Future Planet Capital, Eos, Maven VCT

## Investors

- Mercia Asset Management (https://capitalatlas.ai/funds/mercia-asset-management) — Seed
- Calculus Capital (https://capitalatlas.ai/funds/calculus-capital) — Seed
- Eli Lilly & Company — Seed
- Tekfen Ventures (https://capitalatlas.ai/funds/tekfen-ventures) — Seed
- Future Planet Capital (https://capitalatlas.ai/funds/future-planet-capital) — Seed
- Eos — Seed
- Maven VCT — Seed
- Maven Capital Partners (https://capitalatlas.ai/funds/maven-capital-partners) — Seed
- Eos Ventures (https://capitalatlas.ai/funds/eos-ventures) — Seed
- Norcliffe Capital (https://capitalatlas.ai/funds/norcliffe-capital) — Seed